InsiderTrades

Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2022-07-01 00:00:00 ET · period of report 2022-06-01 · accession 0001209191-22-040099 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2022-07-01 2022-06-01+ CPIX Krogulski Kenneth Dir P - Purchase $2.04 +2,717 190.0K +1% +$5,548

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-06-29 P A 143 $2.11 190,191 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
2 Common Common Stock 2022-06-30 P A 143 $2.08 190,334 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
3 Common Common Stock 2022-06-01 P A 127 $2.05 187,744 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
4 Common Common Stock 2022-06-02 P A 127 $2.08 187,871 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
5 Common Common Stock 2022-06-03 P A 127 $2.09 187,998 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
6 Common Common Stock 2022-06-06 P A 136 $2.07 188,134 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
7 Common Common Stock 2022-06-07 P A 100 $2.08 188,234 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
8 Common Common Stock 2022-06-08 P A 136 $2.12 188,370 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
9 Common Common Stock 2022-06-09 P A 136 $2.09 188,506 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
10 Common Common Stock 2022-06-10 P A 136 $2.04 188,642 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
11 Common Common Stock 2022-06-13 P A 136 $2.01 188,778 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
12 Common Common Stock 2022-06-14 P A 136 $2.02 188,914 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
13 Common Common Stock 2022-06-15 P A 136 $1.98 189,050 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
14 Common Common Stock 2022-06-16 P A 136 $1.95 189,186 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
15 Common Common Stock 2022-06-17 P A 136 $1.94 189,322 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
16 Common Common Stock 2022-06-21 P A 143 $1.97 189,465 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
17 Common Common Stock 2022-06-22 P A 139 $1.99 189,604 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
18 Common Common Stock 2022-06-23 P A 143 $2.01 189,747 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
19 Common Common Stock 2022-06-24 P A 143 $2.11 189,890 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
20 Common Common Stock 2022-06-27 P A 26 $2.06 189,916 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
21 Common Common Stock 2022-06-28 P A 132 $2.06 190,048 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.